| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
Clinical summary: This entry requires a disease-specific recognition, red-flag and emergency-management review. Refer to the underlying article and current local pathway; do not use this panel as a treatment protocol.
Browse the Rheumatology textbook: Rheumatology: Emergencies, pregnancy and other systemic diseases (specialty landing page only; no disease-level match confirmed)
References: Existing source link (not yet checked)
Editorial draft: the full historic text, doses, and pathways have not been clinically signed off. Cross-check BNF/BNFC and local protocols.
Related Subjects: |Systemic Lupus Erythematosus (SLE) |Drug induced Lupus Erythematosus |Discoid lupus erythematosus (DLE) |Neonatal Lupus Erythematosus |Raynaud's Phenomenon |Polymyositis |Dermatomyositis |Polyarteritis nodosa |Rheumatoid Arthritis |Systemic Sclerosis (Scleroderma) |Rheumatology Autoantibodies |Overlap Syndrome |Inclusion Body Myositis |Inflammatory Myopathies |Psoriatic Arthritis |Adult Onset Still's Disease |Alkaptonuria |Behcet's Syndrome
💊 Drug-induced lupus erythematosus (DILE) is an autoimmune condition caused by a reaction to certain medications. ⚠️ It tends to be more benign than idiopathic SLE, with rare renal, skin, or neurological involvement.
| Feature | Drug-Induced Lupus | Systemic Lupus (SLE) |
|---|---|---|
| Age | Older | Younger (esp. women of childbearing age) |
| Time course | Months–years after exposure | Chronic/relapsing |
| Renal/CNS involvement | Rare | Common |
| ANA | Positive, homogeneous | Positive, mixed patterns |
| Anti-dsDNA | Negative | Positive (specific) |
| Anti-histone | Positive in >95% | Positive in 50–70% |
| Management | Stop drug → resolution | Immunosuppression needed |
Teaching Point 🩺: DILE resembles SLE but usually spares the kidneys and CNS. Hallmarks are exposure to culprit drugs (hydralazine, procainamide, isoniazid, minocycline, anti-TNF agents), positive ANA/anti-histone antibodies, and resolution after withdrawal.